News
Market Data
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current BLPH market cap is 1.25M. The company's latest EPS is USD -1.6212 and P/E is -0.06.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 5.64M | 0 | 0 |
| Operating Income | -5.12M | -5.09M | 1.48M | -5.26M | -2.17M |
| Net Income | -5.07M | -5.02M | 2.82M | -5.14M | -1.92M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -27.88M | -17.47M | -26.28M | -20.16M | -22.38M |
| Net Income | 2.81M | -13.27M | -24.73M | -17.76M | -19.83M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 12.61M | 7.94M | 15.97M | 11.25M | 4.98M |
| Total Liabilities | 5.18M | 5.4M | 5.36M | 5.62M | 1.26M |
| Total Equity | 7.43M | 2.53M | 10.6M | 5.62M | 3.72M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 18.36M | 13.11M | 50.24M | 26.88M | 7.94M |
| Total Liabilities | 14.5M | 9.52M | 11.99M | 5.26M | 5.4M |
| Total Equity | 3.86M | 3.59M | 38.25M | 21.62M | 2.53M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -13.42M | -17.77M | 3.27M | -1.66M | -7.99M |
| Investing | N/A | N/A | N/A | N/A | 140k |
| Financing | N/A | -40k | 4.98M | 5.01M | 5.01M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -15.5M | -12.94M | -19.88M | -22.82M | -17.77M |
| Investing | 3M | N/A | N/A | N/A | N/A |
| Financing | 166k | 6.17M | 57.57M | N/A | -40k |
| Market Cap | 1.25M |
| Price to Earnings Ratio | -0.06 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.18 |
| Price to Book Ratio | 0.48 |
| Dividend Yield | - |
| Shares Outstanding | 12.23M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -98.98% |
| 52 Week High | 11.15 |
| 52 Week Low | 0.076 |
| Spread (Intraday) | 0 (1.67%) |
| Company Name | Bellerophon Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.bellerophon.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
